Answer
Ryeqo contains norethisterone acetate, a progestogen, to reduce estrogen-induced endometrial hyperplasia risk in women who have not had a hysterectomy, because unopposed estrogens promote endometrial growth and increase the risk of hyperplasia and cancer.
Sources for this answer
- Ryeqo 40mg/1mg/0.5mg film-coated tabletsGedeon Richter (UK) Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 6Document updated
Sources checked